China's 'Deep Sea Space Station' Will Be 6,500ft Underwater
The world's oceans, covering 70 percent of the earth, are vast, ominous, and largely unexplored. According to a June, 2024 report from NOAA, only 26.1 percent of the ocean floor has been mapped. That's staggeringly low; that's like looking at a photo of a person, trying to see a clear picture of their face, and only getting an ear, or an eyeball. If it were a dating app, you'd undoubtedly swipe left.
But China recently announced a project aimed at exploring the unexplored, getting a clearer picture of the ocean's mysteries. And they're doing so by going straight to the source – 2,000 meters (6,561 feet) beneath the surface. Still, that's only about half the depth of the sunken remains of the Titanic (12,500 feet off eastern Canada). But hey, it's a full-on research station down there.
Per Oceanographic Magazine, the station, which will be located in the South China Sea, 'is expected to be completed by 2030 with the ability to accommodate up to six scientists at a time who will inhabit the 'deep sea space station' for up to a month at a time.
'It has been reported that the primary focus of the facility will be the study of 'cold seep' ecosystems in the area. These are unique environments that have previously been found to be teeming with life as well as home to vast deposits of methane hydrates, a resource earmarked for its potential source of energy.'Details surrounding what this facility will look like are scarce. But sci-fi fantasies abound…hence the video above.
And just for reference, what's the deepest that humans have ever gone in the ocean? That happened back in 2020, when a crew aboard the Challenger Deep vessel sunk down the Mariana Trench in the Pacific (the deepest point in all the oceans, at least that we know) and reached 10,927 meters – that's 35,849 feet, or 6.7 miles.
What will the Chinese find down there? TBD.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
26 minutes ago
- CNBC
Chinese couple charged with smuggling a biological pathogen into the U.S.
A Chinese researcher in Michigan and her boyfriend have been charged with smuggling a biological pathogen that "can cause devastating diseases in crops" into the United States, according to federal charging documents unsealed Tuesday. Yunqing Jian, 33, a postdoctoral fellow at the University of Michigan, and her boyfriend, Zunyong Liu, 34, were charged with multiple counts, including conspiracy to defraud the United States, smuggling goods into the country and making false statements to investigators, the complaint says. Liu was entering the country at Detroit Metropolitan Airport in July when border officers found the pathogen, a fungus known as Fusarium graminearum, in his backpack, according to the complaint. The small clumps of reddish plant material were discovered in four plastic baggies tucked into a wad of tissues. Liu and his girlfriend researched the pathogen as university students in China, the complaint says. Since 2023, Jian had been working at the University of Michigan's Molecular Plant-Microbe Interaction Laboratory. Liu initially told the officers that he did not know what the materials were and that someone must have planted them in his bag, but he then told a different story, the complaint says. "Liu stated that he intentionally hid the samples in his backpack because he knew there were restrictions on the importation of the materials," the complaint says. "Liu confirmed that he had intentionally put the samples in a wad of tissues so CBP Officers would be less likely to find and confiscate them, and he could continue his research in the United States." According to the complaint, Liu also said he planned to use the University of Michigan laboratory to conduct research on the pathogen. When investigators spoke to Jian, she denied knowing anything about Liu's smuggling or plans to research the pathogen, the complaint says. But an examination of Liu's and Jian's electronic devices uncovered WeChat messages from 2022 in which they discussed smuggling seeds into the United States. "I put them in my Martin boots," Liu wrote, according to the complaint. "In a small bag. The ziplock bag. Very small." "That's good," Jian replied, the complaint says. "Just put it in your shoes." At a federal court hearing Tuesday afternoon, a judge ordered Jian to remain behind bars after prosecutors described her as a flight risk. Liu, who was not allowed into the country after the pathogen was allegedly discovered in his backpack, remains at large. The FBI Counterintelligence Division conducted the investigation. "Fusarium graminearum is responsible for billions of dollars in economic losses worldwide each year," the complaint says. "The toxins produced by Fusarium graminearum cause vomiting, liver damage, and reproductive defects in livestock and humans." U.S. Attorney Jerome Gorgon said in a statement: "The alleged actions of these Chinese nationals — including a loyal member of the Chinese Communist Party — are of the gravest national security concerns." The Chinese Embassy in Washington did not immediately respond to a request for comment. The University of Michigan said it condemns "any actions that seek to cause harm, threaten national security or undermine the university's critical public mission." "It is important to note that the university has received no funding from the Chinese government in relation to research conducted by the accused individuals," the university added in a statement. "We have and will continue to cooperate with federal law enforcement in its ongoing investigation and prosecution."
Boston Globe
3 hours ago
- Boston Globe
From no hope to a potential cure for a deadly blood cancer
A third responded so well that they got what seems to be an astonishing reprieve. The immunotherapy developed by Legend Biotech, a company founded in China, seems to have made their cancer disappear. And after five years, it still has not returned in those patients -- a result never before seen in this disease. Advertisement These results, in patients whose situation had seemed hopeless, has led some battle-worn American oncologists to dare to say the words 'potential cure.' Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up 'In my 30 years in oncology, we haven't talked about curing myeloma,' said Dr. Norman Sharpless, a former director of the National Cancer Institute who is now a professor of cancer policy and innovation at the University of North Carolina School of Medicine. 'This is the first time we are really talking seriously about cure in one of the worst malignancies imaginable.' The new study, reported Tuesday at the annual conference of the American Society of Clinical Oncology and published in The Journal of Clinical Oncology, was funded by Johnson & Johnson, which has an exclusive licensing agreement with Legend Biotech. The 36,000 Americans who develop multiple myeloma each year face an illness that eats away at bones, so it looks as if holes have been punched out in them, said Dr. Carl June, of the University of Pennsylvania. Bones collapse. June has seen patients who lost 6 inches in height. Advertisement 'It's a horrible, horrible death,' June said. 'Right now advanced myeloma is a death sentence.' (June has immunotherapy patents that are owned by his university.) There have been treatment advances that increased median survival from two years to 10 over the past two decades. But no cures. Dr. Peter Voorhees of the Atrium Health Levine Cancer Institute in North Carolina and the Wake Forest University School of Medicine, who is lead researcher for the newly published study, said patients usually go through treatment after treatment until, ultimately, the cancer prevails, developing resistance to every class of drug. They end up with nothing left to try. The Legend immunotherapy is a type known as CAR-T. It is delivered as an infusion of the patient's own white blood cells that have been removed and engineered to attack the cancer. The treatment has revolutionized prospects for patients with other types of blood cancer, like leukemia. Making CAR-T cells, though, is an art, with so many possible variables that it can be hard to hit on one that works. And it can have severe side effects including a high fever, trouble breathing and infections. Patients can be hospitalized for weeks after receiving it. But Legend managed to develop one that works in multiple myeloma, defying skeptics. The Chinese company gained attention for its CAR-T eight years ago when it made extravagant claims, which were met by snickers from American researchers. Advertisement Johnson & Johnson, though, was looking for a CAR-T to call its own. So, said Mark Wildgust, an executive in the oncology section of the American drug giant, the company sent scientists and physicians to China to see if the claims were true. 'We went site by site to look at the results,' he said. The company was convinced. It initiated a collaboration with Legend and began testing the treatment in patients whose myeloma had overcome at least one standard treatment. Compared with patients who had standard treatment, those who had the immunotherapy lived longer without their disease progressing. The immunotherapy received regulatory approval in that limited setting and is sold under the brand name Carvykti. The study did not determine whether this difficult treatment saved lives. The new study took on a different challenge -- helping patients at the end of the line after years of treatments. Their immune systems were worn down. They were, as oncologists said, 'heavily pretreated.' So even though CAR-T is designed to spur their immune systems to fight their cancer, it was not clear their immune systems were up to it. Oncologists say that even though most patients did not clear their cancer, having a third who did was remarkable. To see what the expected life span would be for these patients without the immunotherapy, Johnson & Johnson looked at data from patients in a registry who were like the ones in its study -- they had failed every treatment. They lived about a year. For Anne Stovell of New York, one of the study patients whose cancer disappeared, the result is almost too good to be true. She says she went through nine drugs to control her cancer after it was diagnosed in 2010, some of which had horrendous side effects. Each eventually failed. Advertisement Taking the Legend CAR-T was difficult -- she said she had spent nearly three weeks in the hospital. But since that treatment six years ago, she has no sign of cancer. She said it was still difficult for her to believe her myeloma is gone. A new ache -- or an old one -- can bring on the fear. 'There's that little seed of doubt,' she said. But in test after test, the cancer has not reappeared. 'It's a relief for me every year to get a bone marrow biopsy,' she said. Myeloma experts applauded the results. Like treatments for many other cancers, treatments for multiple myeloma come with a high price. The drugs are 'hideously expensive,' June said, costing more than $100,000 a year. The total cost over the years can be millions of dollars, June said, usually paid by insurers, 'and it doesn't even cure you.' CAR-T is expensive too. Carvykti's list price is $555,310. But it is a one-time treatment. And, more important, the hope is that perhaps by giving it earlier in the course of the disease, it could cure patients early on. Johnson & Johnson is now testing that idea. Dr. Kenneth Anderson, a myeloma expert at Dana-Farber Cancer Institute who was not involved with the study, said that if the treatment is used as a first-line treatment, 'cure is now our realistic expectation.' That, at least, is the hope, Sharpless said. And for those like the patients in the new study who are living at least five years -- so far -- without disease, the outcome 'really is eye-popping,' Sharpless said. Advertisement 'That's getting to a point where you wonder if it will ever come back,' he added. This article originally appeared in
Yahoo
4 hours ago
- Yahoo
A Long-Time Meteorologist Shared A Chilling Example Of How Trump's Budget Cuts Will Hurt Weather Predictions
An Emmy-winning TV meteorologist of over three decades is sounding the alarm on the Trump administration's unprecedented cuts to the National Oceanic and Atmospheric Administration ahead of what is expected to be an intense 2025 hurricane season. Florida's John Morales, forecaster at Miami-based news station NBC 6, spoke about the changes Sunday by pointing to the accuracy of a report he was able to give six years ago. Morales played a clip of himself speaking about Hurricane Dorian, which followed the coastline up Florida and along the Southeastern U.S. in 2019. Initially, its movements made it appear like it was on track to smash right into South Florida. 'There is a lot of anxiety out there, because you don't see it turning,' he said at the time. 'It's going to turn,' he said calmly. As the broadcast cut back to a live feed, Morales recalled the confidence he had been able to project back then, despite fears from the community. 'I am here to tell you that I am not sure I can do that this year,' Morales told viewers. Related: A Republican's Response To A "Tax The Rich" Chant At His Town Hall Is Going Viral 'Because of the cuts, the gutting, the sledgehammer attack on science in general,' he went on, 'And I could talk about that for a long, long time, and how that is affecting the U.S. leadership in science over many years, and how we're losing that leadership and this is a multi-generational impact on science in this country.' He added, 'But, specifically, let's talk about the federal government cuts to the national weather service and to NOAA.' President Donald Trump and adviser Elon Musk's efforts to cut federal spending on what they consider 'waste, fraud, and abuse' led the so-called Department of Government Efficiency to eliminate hundreds of NOAA jobs this year, including many within the National Weather Service. Related: "I Am So Torn With What You Are Doing" — 11 Posts From MAGA Business Owners Who Are So Close To Getting It Project 2025 — the blueprint for a second Trump term that he has tried to denounce even as its plans become reality — outlines more extreme disruptions, including the total dismantling of NOAA. 'I think people are nervous and very scared to see what happens next,' a general forecaster at the National Weather Service told HuffPost back in March, after the job cuts, noting that hurricane season picks up in mid-summer. 'Everything people see on TV or hear from The Weather Channel, all that information comes from the National Weather Service,' the employee said. 'We're the ones behind the scenes that you may not see.' The administration did not boost confidence when it emerged that the new head of the Federal Emergency Management Agency, which handles post-hurricane damage, said Monday that he was not aware the country had a hurricane season. (The agency later said the comment was a joke.) Morales told viewers on Sunday that NWS offices in Central and South Florida were 19% to 39% understaffed, and that there has been a 17% drop in weather balloon launches, resulting in less data. JohnMoralesTV / Via 'And what we're starting to see is that the quality of the forecasts is becoming degraded,' Morales said, adding that hurricane-hunting planes may also be affected. 'With less reconnaissance missions, we may be flying blind, and we may not exactly know how strong a hurricane is before reaching the coastline,' he said. The meteorologist had more to say in a written piece published over the weekend. During an extreme weather event, skeleton staff at the nation's weather agencies might be at risk of making mistakes or overlooking data simply due to exhaustion. 'Am I worried? You bet I am!' he wrote. He provided an example of how such mistakes can have a devastating impact: Hurricane Otis, which made landfall near Acapulco, Mexico, in 2023. The storm had drastically more intense wind speeds than predicted, Morales said, in part because there had not been 'timely reconnaissance data' from hurricane-hunting flights. Morales urged viewers to contact their congressional representatives to demand an end to the cuts. This article originally appeared on HuffPost. Also in In the News: People Can't Believe This "Disgusting" Donald Trump Jr. Post About Joe Biden's Cancer Diagnosis Is Real Also in In the News: Miss USA's 2024 "National Costume" Has Been Revealed, And It's Obviously An Interesting Choice Also in In the News: One Body Language Expert Spotted Something Very Telling When Donald Trump "Held His Own Hand" At His Recent Press Conference
